Treatment of inflammatory bowel disease
US5294630A · kind A · utility
18Cited by
3References
19Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 7, 1992 |
| Grant date | Mar 15, 1994 |
| Priority date | — |
| Expiry date | Jul 7, 2012 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P29/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Inflammatory bowel disease is treated, and patients are protected from a relapse into active disease, by the administration of a compound chosen from a series of 3-phenyl-5-carboxypyrazoles and isothiazoles.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.